BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Policy

  Biotechnology Industry Organization (BIO) Applauds EPA’s Rejection of a Petition to Retroactively Waive the 2011 Renewable Fuel Standard

  May 29, 2012

   · 

  1 min read
• BioForest

  Cell Therapeutics, Inc. Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock

  May 29, 2012

   · 

  8 min read
• Policy

  Genzyme Corporation and Isis Pharmaceuticals, Inc. Announce Filing of U.S. NDA for KYNAMRO™ (mipomersen sodium) in Homozygous Familial Hypercholesterolemia

  May 29, 2012

   · 

  9 min read
• BioForest

  Dendreon Corporation Announces Webcast Presentations at Upcoming Conferences

  May 29, 2012

   · 

  1 min read
• Policy

  Watson Pharmaceuticals, Inc. Announces Lidoderm® Patent Challenge Settlement

  May 29, 2012

   · 

  4 min read
• Precise Biometrics AB Kicks Off Global Launch of Tactivo™ for iPhone and iPad

  May 29, 2012

   · 

  1 min read
• Business

  Etienne Veber Joins Precise Biometrics AB as Chief Commercial Officer

  May 29, 2012

   · 

  1 min read
• Drug Development

  Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers

  May 29, 2012

   · 

  1 min read
• Policy

  Janssen Therapeutics Release: FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet

  May 29, 2012

   · 

  8 min read
• Oramed Pharmaceuticals Inc. Granted Core Technology Patent in New Zealand

  May 29, 2012

   · 

  4 min read